0001567619-21-008995.txt : 20210504
0001567619-21-008995.hdr.sgml : 20210504
20210504165516
ACCESSION NUMBER: 0001567619-21-008995
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210430
FILED AS OF DATE: 20210504
DATE AS OF CHANGE: 20210504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adams Gabrielle B.
CENTRAL INDEX KEY: 0001651089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 21889470
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2021-04-30
0
0000722723
HANGER, INC.
HGR
0001651089
Adams Gabrielle B.
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
Vice President Accounting
Common Stock
2021-04-30
4
M
0
20938
12.77
A
80961
D
Common Stock
2021-04-30
4
S
0
20938
25.0257
D
60023
D
Stock Options (right to buy)
12.77
2021-04-30
4
M
0
20938
0
D
2027-05-19
Common Stock
20938
0
D
The transaction by Ms. Adams was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Ms. Adams entered into this trading plan on March 8, 2021 and additional periodic sales may occur under this plan through the end of 2021 if the conditions of the plan are met.
These shares were sold at a range of sale prices from $25.00 to $25.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares totaling 4,227 shares of stock from an initial grant of 4,227 shares of restricted stock that begins to vest on March 8, 2022;(ii) unvested restricted shares totaling 3,230 shares of stock from an initial grant of 3,583 shares of restricted stock that begins to vest on March 9, 2021; (iii) unvested restricted shares totaling 3,800 shares of stock from an initial grant of 4,215 shares of restricted stock that begins to vest on March 9, 2021; (iv) unvested restricted shares and fully vested shares totaling 3,095 shares of stock from an initial grant of 3,854 shares of restricted stock made on March 8, 2019; (v) unvested restricted shares and fully vested shares totaling 3,668 shares of stock from an initial grant of 4,567 shares of restricted stock made on March 8, 2019; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 3,180 shares of stock from an initial grant of 4,435 shares of restricted stock made on March 8, 2019; (vii) unvested restricted shares and fully vested shares totaling 3,997 shares of stock from an initial grant of 5,574 shares of restricted stock made on March 9, 2018; (viii) unvested restricted shares and fully vested shares totaling 5,710 shares of stock from an initial grant of 7,950 shares of restricted stock made on March 8, 2017; [continued in next footnote]
(ix) fully vested shares totaling 2,446 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; (x) unvested restricted shares and fully vested shares totaling 6,233 shares of stock from an initial grant of 7,750 shares of restricted stock made on April 29, 2016; (xi) fully vested shares which total 3,020 shares of stock from an initial grant of 3,305 shares of restricted stock made on November 10, 2015; [continued in next footnote]
(xii) fully vested shares which total 2,037 shares of stock from an initial grant of 2,229 shares of restricted stock made on September 8, 2015; and (xiii) fully vested shares which total 3,818 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
Jessica Lochmann Allen, Attorney-in-Fact for Gabrielle B. Adams
2021-05-04